Tse Wen Chang
id:
tse-wen-chang-171-7853076
title:
Tse Wen Chang
text:
Tse Wen Chang is an immunology researcher, whose career spans across academia and industry. His early research involving the Immunoglobulin E (IgE) pathway and antibody-based therapeutics lead to the development of omalizumab, a medication that has been approved for the treatment of severe allergic asthma and severe chronic spontaneous urticaria. Chang is a cofounder of Tanox, a biopharmaceutical company specialized in anti-IgE therapies for the treatment of allergic diseases. After Tanox's trip
brand slug:
wiki
category slug:
encyclopedia
description:
Taiwanese immunologist (born 1947)
original url:
https://en.wikipedia.org/wiki/Tse_Wen_Chang
date created:
2017-05-11T20:26:43Z
date modified:
2024-09-01T08:56:33Z
main entity:
{"identifier":"Q30089936","url":"https://www.wikidata.org/entity/Q30089936"}
image:
fields total:
13
integrity:
15